Goodwill and Other Intangible Assets

3 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

4. Goodwill and Other Intangible Assets

Goodwill

The following table summarizes the changes in the carrying amount of goodwill by segment and in total:



(in millions)	Pharmaceutical			Medical		Total
Balance at June 30, 2016	$	2,919		$	4,248	$	7,167
Goodwill acquired, net of purchase price adjustments	9			86		95
Foreign currency translation adjustments and other	(2		)	1		(1		)
Balance at September 30, 2016	$	2,926		$	4,335	$	7,261

Other Intangible Assets

The following tables summarize other intangible assets by class at:



	September 30, 2016
(in millions)	Gross Intangible		Accumulated Amortization		Net Intangible		Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles:
IPR&D, trademarks and other	$	70	$	—	$	70	N/A
Total indefinite-life intangibles	70		—		70		N/A

Definite-life intangibles:
Customer relationships	1,931		793		1,138		9
Trademarks, trade names, and patents	527		156		371		14
Developed technology and other	812		225		587		8
Total definite-life intangibles	3,270		1,174		2,096		10
Total other intangible assets	$	3,340	$	1,174	$	2,166	N/A



	June 30, 2016
(in millions)	Gross Intangible		Accumulated Amortization		Net Intangible
Indefinite-life intangibles:
IPR&D, trademarks and other	$	72	$	—	$	72
Total indefinite-life intangibles	72		—		72

Definite-life intangibles:
Customer relationships	1,946		737		1,209
Trademarks, trade names, and patents	508		140		368
Developed technology and other	808		198		610
Total definite-life intangibles	3,262		1,075		2,187
Total other intangible assets	$	3,334	$	1,075	$	2,259

Total amortization of intangible assets was $101 million and $67 million for the three months ended September 30, 2016 and 2015, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal 2017 through 2021 is as follows: $285 million, $350 million, $281 million, $254 million, and $207 million.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details